Stroke is the most common cause of epilepsy in older adults, but there is limited information about rates and risk factors in this population.
Epilepsy and Seizure
Previous studies of methylphenidate in epilepsy patients have suffered from small numbers and methodological issues, such as lack of blinding.
January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.
Orthostatic hypotension’s effect on cognition in Parkinson disease, testing patients with epilepsy who can drive safely, and carotid web are covered.
Research from AES 2016 explored relationships between epilepsy and other neurological disorders, including Alzheimer disease, MS, stroke, and autism.
November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.
Tumor-related epilepsy is poorly controlled by antiepileptic drugs, and the best management of tumor-related focal epilepsies remains controversial.
Case 1 (of 4): Increasingly disruptive behavior and possible deteriorating cognitive function in a young girl with a previous right hemispherectomy.
After failed drug interventions, surgeries, & alternative therapies, is there a point at which to stop additional treatments for intractable epilepsy?
Antiepileptic drugs, insomnia, and obstructive sleep apnea may all affect the already complicated relationship between epilepsy and sleep.